B‐cell maturation antigen chimeric antigen receptor‐T therapy alleviated heart failure in patients with multiple myeloma

A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation

(2023) Vincenzo Nuzzi et al.   European Heart Journal - Case Reports

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

(2021) Nikhil C. Munshi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis

(2021) Giovanni Palladini et al.   Cells

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)

(2014) A. Jaccard et al.   HAEMATOLOGICA

High Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis

(2014) Vaishali Sanchorawala   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.

(2013) A Dispenzieri et al.   BONE MARROW TRANSPLANTATION

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

(2012) Giovanni Palladini et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients With Previous Diagnosis of Multiple Myeloma

(2010) Sumit Madan et al.   MAYO CLINIC PROCEEDINGS